ロード中...
In vitro chondrogenic potency of surplus chondrocytes from autologous transplantation procedures does not predict short-term clinical outcomes
BACKGROUND: Autologous chondrocyte implantation (ACI) has been used over the last two decades to treat focal cartilage lesions aiming to delay or prevent the onset of osteoarthritis; however, some patients do not respond adequately to the procedure. A number of biomarkers that can forecast the clini...
保存先:
| 出版年: | BMC Musculoskelet Disord |
|---|---|
| 主要な著者: | , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
BioMed Central
2019
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6329094/ https://ncbi.nlm.nih.gov/pubmed/30630436 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12891-018-2380-4 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|